Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 27 citing articles:

Treatment of chronic kidney disease in older populations
Seiji Kishi, Hiroyuki Kadoya, Naoki Kashihara
Nature Reviews Nephrology (2024) Vol. 20, Iss. 9, pp. 586-602
Closed Access | Times Cited: 17
Frailty, Sarcopenia, Cachexia, and Malnutrition in Heart Failure
Daichi Maeda, Yudai Fujimoto, Taisuke Nakade, et al.
Korean Circulation Journal (2024) Vol. 54, Iss. 7, pp. 363-363
Open Access | Times Cited: 13
Research advances in the anti-inflammatory effects of SGLT inhibitors in type 2 diabetes mellitus
Ruining Zhang, Qingxing Xie, Xi Lu, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition)
Lixin Guo, Xinhua Xiao
Aging Medicine (2024) Vol. 7, Iss. 1, pp. 5-51
Open Access | Times Cited: 9
Effect of empagliflozin on weight in patients with prediabetes and diabetes
Mojgan Sanjari, Mohammad Hadavizadeh, Narges Sadeghi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
The efficacy and safety of sodium‐glucose cotransporter 2 inhibitors in patients aged over 80 years with heart failure
Kenji Nakano, Kenji Kanenawa, Akihiro Isotani, et al.
ESC Heart Failure (2025)
Open Access
Epidemiological characteristics and risk factors for heart failure in Japanese patients with type 2 diabetes: A retrospective analysis of the J‐DREAMS database
Mitsuru Ohsugi, Daisuke Nitta, Yusuke Naito, et al.
Journal of Diabetes Investigation (2025)
Open Access
Impact of SGLT2 inhibitors on survival in gastrointestinal cancer patients undergoing chemotherapy and/or radiotherapy: a real-world data retrospective cohort study
Lucas E. Flausino, Alexis Germán Murillo Carrasco, Tatiane Katsue Furuya, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Sodium-Glucose Cotransporter 2 Inhibitors Improve Body Composition by Increasing the Skeletal Muscle Mass/Fat Mass Ratio in Patients with Type 2 Diabetes: A 52-Week Prospective Real-Life Study
Sara Volpe, Alfredo Vozza, Giuseppe Lisco, et al.
Nutrients (2024) Vol. 16, Iss. 22, pp. 3841-3841
Open Access | Times Cited: 3
The Safety and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors for Patients with Sarcopenia or Frailty: Double Edged Sword?
Ayami Naito, Yuji Nagatomo, Akane Kawai, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 2, pp. 141-141
Open Access | Times Cited: 2
Safety and effectiveness of tofogliflozin in Japanese people with type 2 diabetes: A multicenter prospective observational study in routine clinical practice
Yuichiro Yamada, Daisuke Yabe, Kenichiro Shide, et al.
Journal of Diabetes Investigation (2024) Vol. 15, Iss. 11, pp. 1585-1595
Open Access | Times Cited: 2
Worldwide burden of antidiabetic drug-induced sarcopenia: An international pharmacovigilance study
Jaehyun Kong, Seoyoung Park, Tae Hyeon Kim, et al.
Archives of Gerontology and Geriatrics (2024) Vol. 129, pp. 105656-105656
Closed Access | Times Cited: 2
Long‐term safety and efficacy of SGLT2 inhibitor use in older east Asians with type 2 diabetes
Yoshihiro Takahashi, Yutaka Seino, Daisuke Yabe
Journal of Diabetes Investigation (2023) Vol. 15, Iss. 1, pp. 63-66
Open Access | Times Cited: 6
Cardiovascular Outcomes With Empagliflozin and Dapagliflozin in Patients Without Diabetes
Sahib Singh, Aakash Garg, Udaya S. Tantry, et al.
The American Journal of Cardiology (2024) Vol. 218, pp. 24-31
Closed Access | Times Cited: 1
Unexpectedly Rapid Onset of Severe Sarcopenia in an Elderly Diabetic Man following SGLT2i Administration: A Case Report
Paulina Czarnecka, Kinga Czarnecka, Olga Tronina
Journal of Clinical Medicine (2024) Vol. 13, Iss. 10, pp. 2828-2828
Open Access | Times Cited: 1
Cost‐effectiveness of sodium‐glucose cotransporter‐2 inhibitors in the treatment of diabetic nephropathy in Japan
Keiko Maruyama‐Sakurai, Hisateru Tachimori, Eiko Saito, et al.
Diabetes Obesity and Metabolism (2024)
Open Access | Times Cited: 1
Slowing the progression of diabetic and non‐diabetic kidney disease: A summary of the current evidence base for sodium‐glucose co‐transporter‐2 inhibitors
Viktor Rotbain Curovic, Elisabeth B. Stougaard, Tine W. Hansen
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S6, pp. 22-32
Closed Access | Times Cited: 1
Adverse events and drug–drug interactions of sodium glucose co-transporter 2 inhibitors in patients treated for heart failure
Claudia Stöllberger, Josef Finsterer, Birke Schneider
Expert Review of Cardiovascular Therapy (2023) Vol. 21, Iss. 11, pp. 803-816
Closed Access | Times Cited: 2
Changes in daily intake of nutrients and foods including confectionery after the initiation of empagliflozin in Japanese patients with type 2 diabetes: a pilot study
Toshiko Murayama, Michihiro Hosojima, Hideyuki Kabasawa, et al.
BMC Nutrition (2024) Vol. 10, Iss. 1
Open Access
Harnessing the Therapeutic Potential of SGLT2 Inhibitors in Type 2 Diabetes: Challenges and Opportunities
Daisuke Yabe
JMA Journal (2024) Vol. 7, Iss. 3, pp. 401-402
Open Access
Impact of age on eGFR dynamics following sodium-glucose cotransporter 2 inhibitor therapy: A real-world study
Hye-Ji An, Jin Jang, S.-G. Lee, et al.
Diabetes Research and Clinical Practice (2024) Vol. 214, pp. 111796-111796
Closed Access
Management of Older Adults with Diabetes According to the 2023 Guidelinesfor Elderly Diabetes
Kentaro Watanabe
Journal of Nihon University Medical Association (2024) Vol. 83, Iss. 2, pp. 51-59
Open Access
Sulfonylurea prescription patterns in elderly patients with type 2 diabetes mellitus: A comprehensive analysis of real‐world data from pharmacies in Japan
Michiko Yamazaki, Tohru Takebe, Masaya Hosokawa, et al.
Journal of Diabetes Investigation (2024)
Open Access
Che cosa non sappiamo sugli SGLT-2 inibitori
Martina Chiriacò, Kyriazoula Chatzianagnostou, Michele Emdin, et al.
L Endocrinologo (2024)
Open Access
Exploring SGLT-2 inhibitors and sarcopenia in FAERS: a post-marketing surveillance study
Zheng Kuai, Yangli Ye, Xiaoyi Zhang, et al.
Expert Opinion on Drug Safety (2024)
Closed Access
Page 1 - Next Page

Scroll to top